BACKGROUND AND PURPOSE: Neurocognitive decline in brain tumor patients treated with radiotherapy (RT) may be linked to cortical atrophy. We developed models to determine radiation treatment-planning objectives for cortex, which were tested on a sample population to identify the dosimetric cost of cortical sparing. MATERIAL AND METHODS: The relationship between the probability of cortical atrophy in fifteen high-grade glioma patients at 1-year post-RT and radiation dose was fit using logistic mixed effects modeling. Cortical sparing was implemented using two strategies: region-specific sparing using model parameters, and non-specific sparing of all normal brain tissue. RESULTS: A dose threshold of 28.6 Gy was found to result in a 20% probability of severe atrophy. Average cortical sparing at 30 Gy was greater for region-specific dose avoidance (4.6%) compared to non-specific (3.6%). Cortical sparing resulted in an increase in heterogeneity index of the planning target volume (PTV) with an average increase of 1.9% (region-specific) and 0.9% (non-specific). CONCLUSIONS: We found RT doses above 28.6 Gy resulted in a greater than 20% probability of cortical atrophy. Cortical sparing can be achieved using region-specific or non-specific dose avoidance strategies at the cost of an increase in the dose heterogeneity of the PTV.
BACKGROUND AND PURPOSE:Neurocognitive decline in brain tumorpatients treated with radiotherapy (RT) may be linked to cortical atrophy. We developed models to determine radiation treatment-planning objectives for cortex, which were tested on a sample population to identify the dosimetric cost of cortical sparing. MATERIAL AND METHODS: The relationship between the probability of cortical atrophy in fifteen high-grade gliomapatients at 1-year post-RT and radiation dose was fit using logistic mixed effects modeling. Cortical sparing was implemented using two strategies: region-specific sparing using model parameters, and non-specific sparing of all normal brain tissue. RESULTS: A dose threshold of 28.6 Gy was found to result in a 20% probability of severe atrophy. Average cortical sparing at 30 Gy was greater for region-specific dose avoidance (4.6%) compared to non-specific (3.6%). Cortical sparing resulted in an increase in heterogeneity index of the planning target volume (PTV) with an average increase of 1.9% (region-specific) and 0.9% (non-specific). CONCLUSIONS: We found RT doses above 28.6 Gy resulted in a greater than 20% probability of cortical atrophy. Cortical sparing can be achieved using region-specific or non-specific dose avoidance strategies at the cost of an increase in the dose heterogeneity of the PTV.
Authors: Stephen R McCauley; Elisabeth A Wilde; Tricia L Merkley; Kathleen P Schnelle; Erin D Bigler; Jill V Hunter; Zili Chu; Ana C Vásquez; Harvey S Levin Journal: Dev Neuropsychol Date: 2010 Impact factor: 2.253
Authors: Roshan Karunamuni; Hauke Bartsch; Nathan S White; Vitali Moiseenko; Ruben Carmona; Deborah C Marshall; Tyler M Seibert; Carrie R McDonald; Nikdokht Farid; Anithapriya Krishnan; Joshua Kuperman; Loren Mell; James B Brewer; Anders M Dale; Jona A Hattangadi-Gluth Journal: Int J Radiat Oncol Biol Phys Date: 2015-10-21 Impact factor: 7.038
Authors: Nikos Makris; Joseph Biederman; Eve M Valera; George Bush; Jonathan Kaiser; David N Kennedy; Verne S Caviness; Stephen V Faraone; Larry J Seidman Journal: Cereb Cortex Date: 2006-08-18 Impact factor: 5.357
Authors: An-Tao Du; Norbert Schuff; Joel H Kramer; Howard J Rosen; Maria Luisa Gorno-Tempini; Katherine Rankin; Bruce L Miller; Michael W Weiner Journal: Brain Date: 2007-03-12 Impact factor: 13.501
Authors: Vyacheslav L Murzin; Kaley Woods; Vitali Moiseenko; Roshan Karunamuni; Kathryn R Tringale; Tyler M Seibert; Michael J Connor; Daniel R Simpson; Ke Sheng; Jona A Hattangadi-Gluth Journal: Radiother Oncol Date: 2018-03-05 Impact factor: 6.280
Authors: Flavie Bompaire; Marion Lahutte; Stephane Buffat; Carole Soussain; Anne Emmanuelle Ardisson; Robert Terziev; Magali Sallansonnet-Froment; Thierry De Greslan; Sébastien Edmond; Mehdi Saad; Christophe Nioche; Thomas Durand; Sonia Alamowitch; Khe Hoang Xuan; Jean Yves Delattre; Jean Luc Renard; Hervé Taillia; Cyrus Chargari; Dimitri Psimaras; Damien Ricard Journal: Support Care Cancer Date: 2018-07-07 Impact factor: 3.603
Authors: J Jacob; L Feuvret; J-M Simon; M Ribeiro; L Nichelli; C Jenny; D Ricard; D Psimaras; K Hoang-Xuan; P Maingon Journal: Neurol Sci Date: 2022-02-11 Impact factor: 3.307